: M42 and Inocras announce strategic collaboration to advance earlier detection of cancer recurrence in the UAE using whole genome powered MRD technology
James Mault, MD, is the Founder and CEO of BioIntelliSense, pioneering a platform that delivers medical-grade biosensors for scalable patient monitoring and clinical intelligence.